– Keymed Biosciences anuncia los resultados anuales de 2022: Promueve eficazmente el progreso clÃnico y desarrolla proactivamente la colaboración estratégica mundial CHENGDU, China, 18 de marzo de 2023 /PRNewswire/ — Keymed Biosciences Inc. (HKEX: 02162) ha anunciado sus resultados…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.